ATP8B1 and ABCB11 Analysis in 62 children with normal gamma-glutamyl transferase Progressive Familial Intrahepatic Cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history

Hepatology

Volumn 51, Issue 5, 2010, Pages 1645-1655

  Davit Spraul, Anne ^a   Fabre, Monique ^a,b   Branchereau, Sophie ^a   Baussan, Christiane ^a   Gonzales, Emmanuel ^a,b,c   Stieger, Bruno ^d   Bernard, Olivier ^a,b   Jacquemin, Emmanuel ^a,b,c  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; BILE ACID; BILE SALT; GAMMA GLUTAMYLTRANSFERASE; RIFAMPICIN; URSODEOXYCHOLIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CHILD; CHOLELITHIASIS; CONTROLLED STUDY; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; INTRAHEPATIC CHOLESTASIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 1; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 2; TREATMENT RESPONSE;

ADENOSINE TRIPHOSPHATASES; ALANINE TRANSAMINASE; ALPHA-FETOPROTEINS; ATP-BINDING CASSETTE TRANSPORTERS; CHILD; CHILD, PRESCHOOL; CHOLESTASIS, INTRAHEPATIC; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INFANT; LIVER; LIVER CIRRHOSIS; PHENOTYPE; RETROSPECTIVE STUDIES; URSODEOXYCHOLIC ACID;

EID: 77951487115     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23539     Document Type: Article

References (32)

1. Davit Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis 2009;4:1.
2. Bull LN, van Eijk MJ, Pawlikowska L, DeYoung JA, Juijn JA, Liao M, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998;18:219-224. (Pubitemid 28117258)
3. Klomp LW, Vargas JC, van Mil SW, Pawlikowska L, Strautnieks SS, Van Eijk MJT, et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. HEPATOLOGY 2004;40:27-38. (Pubitemid 38868920)
4. Cai SY, Gautam S, Nguyen T, Soroka CJ, Rahner C, Boyer JL. ATP8B1 disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained. Gastroenterology 2009;136:1060-1069.
5. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998;20:233-238. (Pubitemid 28507666)
6. Van Mil S, van der Woerd WL, van der Brugge G, Sturm E, Jansen PLM, Bull LN, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004;127:379-384. (Pubitemid 39091885)
7. Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerová D, Rayner A, Dutton L, et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 2008;134:1203-1214.
8. Lykavieris P, van Mil S, Cresteil D, Fabre M, Hadchouel M, Klomp L, et al. Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol 2003;39:447-452.
9. Jansen PLM, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJEJ, et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999;117:1370-1379.
10. Chen HL, Chang PS, Hsu HC, Ni YH, Hsu HY, Lee JH, et al. FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low alpha-glutamyltranspeptidase levels. J Pediatr 2002;140:119-124.
11. Lang C, Meier Y, Stieger B, Ulrich B, Lang T, Kerb R, et al. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics 2007;17:47-60. (Pubitemid 46183791)
12. Pauli-Magnus C, Lang T, Meier Y, Zodan-Marin T, Jung D, Breymann C, et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 2004;14:91-102.
13. Alonso EM, Snover DC, Montag A, Freese DK, Whitington PF. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994;18:128-133. (Pubitemid 24056468)
14. Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Harp HL. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994;18:134-141. (Pubitemid 24056469)
15. Bull LN, Carlton VE, Stricker NL, Baharloo S, DeYoung JA, Freimer NB, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. HEPATOLOGY 1997;26:155-164. (Pubitemid 27280320)
16. Stapelbroek JM, Peters TA, van Beurden DHA, Curfs JH, Joosten A, Beynon AJ, et al. ATP8B1 is essential for maintaining normal hearing. Proc Natl Acad Sci U S A 2009;106:9709-9714.
17. Myagawa-Hayashino A, Egawa H, Yorifuji T, Hasegawa M. Haga H, Tsuruyama T et al. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation. Liver Transpl 2009;15:610-618.
18. Maggiore G, Bernard O, Riely CA, Hadchouel M, Lemonnier A, Alagille D. Normal c-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis. J Pediatr 1987;111:251-252. (Pubitemid 17122336)
19. Jacquemin E, Hermans D, Myara A, Habes D, Debray D, Hadchouel M, et al. Ursodeoycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. HEPATOLOGY 1997;25:519-523. (Pubitemid 27106425)
20. Jacquemin E, Dumont M, Bernard O, Erlinger S, Hadchouel M. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease). Eur J Pediatr 1994;153:424-428. (Pubitemid 24183780)
21. Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology 1990;98:1013-1016. (Pubitemid 20095855)
22. Emond JC, Whitington PF. Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease). J Pediatr Surg 1995;30:1635-1641.
23. Houdayer C, Dehainault C, Mattler C, Michaux D, Caux-Moncoutier V, Pages-Berhouet S, et al. Evaluation of in silico tools for decision making in molecular diagnosis. Hum Mut 2008;29:975-982. (Pubitemid 351951292)
24. Noe J, Stieger B, Meier PJ. Functional expression of the canalicular bile salt export pump of human liver. Gastroenterology 2002;123:1659-1666. (Pubitemid 35231665)
25. Jacquemin E, de Vree JLM, Cresteil D, Sokal EM, Sturm E, Dumont M, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001;120:1448-1458. (Pubitemid 32322319)
26. Byrne JA, Strautnieks SS, Ihrke G, Pagani F, Knisely AS, Linton KJ, et al. Missense mutations and single nucleotide polymorphisms in ABCB11 impair BSEP processing and function or disrupt pre-mRNA splicing. HEPATOLOGY 2009;49:553-567.
27. Cutillo L, Najimi M, Smets F, Janssen M, Reding R, de Ville de Goyet J, et al. Safety of living-related liver transplantation for progressive familial intrahepatic cholestasis. Pediatr Transpl 2006;10:570-574.
28. Ismail H, Kalicinski P, Markiewicz M, Jankowska I, Pawłowska J, Kluge P, et al. Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion. Pediatr Transpl 1999;3:219-224. (Pubitemid 29399943)
29. Arnell H, Bergdahl S, Papadogiannakis N, Nemeth A, Fischler B. Preoperative observations and short-term outcome after partial external biliary diversion in 13 patients with progressive familial intrahepatic cholestasis. J Pediatr Surg 2008;43:1312-1320. (Pubitemid 351970530)
30. Yang H, Porte RJ, Verkade HJ, De Langen ZJ, Hulscher JBF. Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease. J Pediatr Gastroenterol Nutr 2009;49:216-221.
31. Emerick KM, Elias M, Melin-Aldana H, Strautnieks S, Thompson RJ, Bull LN, et al. Bile composition in Alagille syndrome and PFIC patients having partial external biliary diversion. BMC Gastroenterol 2008;8:47.
32. Hayashi H, Sugiyama Y. 4-Phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps. HEPATOLOGY 2007;45:1506-1516. (Pubitemid 46918335)